Stock data
Sun Pharmaceutical Industries$18.16
SUNPHARMA 
0.23% • 24 H
0.23% • 24 HDividend Yield:0.7%
Global Rank#399
Market Cap$43.58B
YTD Performance20.27%
P/E0.51
Revenue$5.18B
Change 7d3.24%
SP500 BenchmarkOutperform
Country🇮🇳 India
P/S8.41
Earnings$1.02B
Dividend Yield:0.7%
Main Sector
Healthcare
Sun Pharmaceutical Industries (SUNPHARMA) Total Liabilities
SUNPHARMA Total Liabilities in 2022: $2.57B
According to Sun Pharmaceutical Industries latest financial reports the total liabilities of SUNPHARMA is $2.57B, an increase of 14.38% to 2022. At the end of 2022 company had $2.24B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Sun Pharmaceutical Industries is responsible for during its operational activities.
Sun Pharmaceutical Industries (SUNPHARMA) Total Liabilities History from 2023 to 2022
-
Value:-
SUNPHARMA Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $2.57B | 14.38% |
| 2022 | $2.24B | 3.01% |
| 2021 | $2.18B | -4.92% |
| 2020 | $2.29B | 26.51% |
| 2019 | $1.81B | - |
View the Top Total Liabilies Stocks
